Literature DB >> 6835724

Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda.

R Baron, J M Gertner, R Lang, A Vignery.   

Abstract

Iliac crest bone biopsies from nine children (6-15 yrs old) with osteogenesis imperfecta tarda (OI) have been studied by bone histomorphometry after double fluorescent labeling with tetracycline and compared to five unlabeled biopsies from normal children in the same age group. The results indicate that children with OI have a low trabecular bone volume associated with an increased bone turnover rate. Bone formation is increased at the tissue level despite a decrease in the activity of individual osteoblasts. The original defects in OI seems, therefore, to be in the rate of matrix synthesis by osteoblasts. It is, however, compensated by an increase in the number of these cells. These results suggest that these children were not losing bone at the time of the biopsy, which fits with the clinical stability of OI with age. Our study therefore suggests that the osteopenia observed in OI is most likely due to an inability to accumulate bone during growth, as normal children do, rather than to a progressive net loss of bone.

Entities:  

Mesh:

Year:  1983        PMID: 6835724     DOI: 10.1203/00006450-198303000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  21 in total

1.  Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.

Authors:  Haitao Li; Xi Jiang; John Delaney; Tiziana Franceschetti; Ines Bilic-Curcic; Judy Kalinovsky; Joseph A Lorenzo; Danka Grcevic; David W Rowe; Ivo Kalajzic
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

2.  Increased susceptibility to microdamage in Brtl/+ mouse model for osteogenesis imperfecta.

Authors:  Mathieu S Davis; Bethany L Kovacic; Joan C Marini; Albert J Shih; Kenneth M Kozloff
Journal:  Bone       Date:  2011-12-20       Impact factor: 4.398

3.  Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α.

Authors:  G Brunetti; F Papadia; A Tummolo; R Fischetto; F Nicastro; L Piacente; A Ventura; G Mori; A Oranger; I Gigante; S Colucci; M Ciccarelli; M Grano; L Cavallo; M Delvecchio; M F Faienza
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

4.  Bone resorptive activity of human peripheral blood mononuclear cells after fusion with polyethylene glycol.

Authors:  Edwin Manrique; Luz M Castillo; Oswaldo Lazala; Carlos A Guerrero; Orlando Acosta
Journal:  J Bone Miner Metab       Date:  2016-03-11       Impact factor: 2.626

Review 5.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

6.  Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta.

Authors:  J P Devogelaer; J Malghem; B Maldague; C Nagant de Deuxchaisnes
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

Review 7.  Hematopoietic stem cells are pluripotent and not just "hematopoietic".

Authors:  Makio Ogawa; Amanda C LaRue; Meenal Mehrotra
Journal:  Blood Cells Mol Dis       Date:  2013-02-27       Impact factor: 3.039

8.  Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse.

Authors:  U T Iwaniec; C H Trevisiol; G F Maddalozzo; C J Rosen; R T Turner
Journal:  Bone       Date:  2008-01-12       Impact factor: 4.398

9.  Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta.

Authors:  Hao Zhang; Stephen B Doty; Christine Hughes; David Dempster; Nancy Pleshko Camacho
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

10.  Variable osteoclast appearance in human infantile osteopetrosis.

Authors:  F Shapiro; L L Key; C Anast
Journal:  Calcif Tissue Int       Date:  1988-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.